jan 1, 2011 - Ipilimumab
Description:
FDA approves the use of ipilimumab, a monoclonal antibody, for the treatment of inoperable or metastatic melanoma. Ipilimumab stimulates the immune system to attack cancer cells by removing a "brake" that normally controls the intensity of immune responses.Added to timeline:
Date:
jan 1, 2011
Now
~ 15 years ago